Stock Events

ARK Genomic Revolution

$30.48

1193

+$0.73+2.44% Today

Statistics

Day High

30.71

Day Low

29.63

52W High

34.24

52W Low

20.34

Volume

83,561

Avg. Volume

Mkt Cap

P/E Ratio

Dividend Yield

Dividend

Expense Ratio

0.75%

1%+

The annual fee that you pay to the fund company for managing your investment. The lower the expense ratio, the better. This is not an investment recommendation.

Dividends

0%Dividend Yield

Dec 21

$0.38

Dec 20

$0.79

Dec 19

$1.05

Dec 18

$0.2

Dec 18

$0.27

10Y Growth

N/A

5Y Growth

N/A

3Y Growth

N/A

1Y Growth

N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ARKG. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Global X Genomics & Biotechnology

GNOM

Mkt Cap0

Global X Genomics & Biotechnology ETF, focuses on companies in genomics, making it a direct competitor to ARKG's thematic investment in genomics and biotech.

iShares Genomics Immunology and Healthcare

IDNA

Mkt Cap0

iShares Genomics Immunology and Healthcare ETF, targets similar genomics and immunology sectors, directly competing with ARKG's investment focus.

Principal Healthcare Innovators

BTEC

Mkt Cap0

Principal Healthcare Innovators Index ETF, invests in healthcare innovation, including genomics, competing in the same thematic space as ARKG.

Invesco Biotechnology & Genome

PBE

Mkt Cap0

Invesco Dynamic Biotechnology & Genome ETF, focuses on biotech and genomic companies, making it a competitor by targeting similar investment themes.

VanEck Biotech

BBH

Mkt Cap0

VanEck Vectors Biotech ETF, while broader in biotech, it includes genomic companies, positioning it as a competitor to ARKG.

State Street SPDR S&P Biotech

XBI

Mkt Cap0

SPDR S&P Biotech ETF, offers broad exposure to biotech, including genomics, competing with ARKG on the thematic investment front.

iShares Biotechnology

IBB

Mkt Cap0

iShares Nasdaq Biotechnology ETF, a broad biotech ETF that includes genomic companies, making it a competitor in the space.

First Trust NYSE Arca Biotechnology Index Fund

FBT

Mkt Cap0

First Trust NYSE Arca Biotechnology Index Fund, although broader, it competes by investing in some of the same genomic and biotech companies as ARKG.

ALPS Medical Breakthroughs

SBIO

Mkt Cap0

ALPS Medical Breakthroughs ETF, focuses on medical breakthroughs, including genomics, positioning it as a thematic competitor.

Virtus Biotech Clinical Trials

BBC

Mkt Cap0

Virtus LifeSci Biotech Clinical Trials ETF, focuses on biotech companies in clinical trials, including genomics, making it a niche competitor.

Holdings

Regions

Sectors

About

ARKG is an actively managed Exchange Traded Fund (ETF) that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors that are relevant to the Fund’s investment theme of the genomics revolution.

CEO

Country

United States

ISIN

US00214Q3020

Listings

0 Comments

Share your thoughts

FAQ

What is ARK Genomic Revolution stock price today?▼

The current price of ARKG is $30.48 USD — it has increased by +2.44% in the past 24 hours. Watch ARK Genomic Revolution stock price performance more closely on the chart.

What is ARK Genomic Revolution stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange ARK Genomic Revolution stocks are traded under the ticker ARKG.

Is ARK Genomic Revolution stock price growing?▼

ARKG stock has risen by +7.05% compared to the previous week, the month change is a +12.01% rise, over the last year ARK Genomic Revolution has showed a +50.12% increase.

Does ARK Genomic Revolution pay dividends?▼

Yes, ARKG dividends are paid semi-annual. The last dividend per share was 0.38 USD. As of today, Dividend Yield (FWD)% is 0%.

In which sector is ARK Genomic Revolution located?▼

ARK Genomic Revolution operates in the Other sector.

When did ARK Genomic Revolution complete a stock split?▼

ARK Genomic Revolution has not had any recent stock splits.